Nasdaq
$2.24▼ 1.54%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $14.3MShares out 6.4M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
13- 10.8Pre-market26.10.08 21:006-KKey event#●●●
Quantum Biopharma Ltd.
Quantum BioPharma announced that the U.S. District Court for the Southern District of New York has consolidated the company's direct action and a class action lawsuit against Canadian banks CIBC and RBC for alleged stock market manipulation. Additionally, the court appointed Grant & Eisenhofer P.A. as lead counsel for the consolidated class action.…more
$2.24-1.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.6Pre-market26.10.06 19:006-KKey event
Quantum Biopharma Ltd.
Quantum BioPharma has entered into a Study Start-Up Agreement (SUA) with Thermo Fisher Scientific to implement the Phase 2 clinical trial of its multiple sclerosis candidate, 'Lucid-MS'. Following FDA clearance, this contract marks the formal initiation of study start-up activities and operational implementation for the Phase 2 trial.…more
$2.24-1.54%vs prev closeView filingShare - 10.5Regular26.10.05 22:39SCHEDULE 13G/AOwnership
Quantum Biopharma Ltd.
AdvisorShares Trust has filed a SCHEDULE 13G/A regarding its beneficial ownership in Quantum Biopharma Ltd. This filing serves to report changes in the investor's equity holdings.…more
$2.24-1.54%vs prev closeView filingShare
12 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.8Pre-market26.10.08 21:00#●●●
Quantum BioPharma Appoints Lead Counsel in Consolidated Lawsuit Against Canadian Banks…more
Quantum BioPharma announced that the U.S. District Court has consolidated its market manipulation lawsuit against Canadian banks and appointed lead counsel. This procedural development does not guarantee a favorable outcome or recovery of damages.…more
$2.24-1.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.6Pre-market26.10.06 18:47
●●●●●●●● ●●●●● ●●●●●●
Quantum BioPharma has partnered with Thermo Fisher Scientific to support its Phase 2 clinical trial for a neuroprotective therapy targeting multiple sclerosis. The financial terms of the agreement were not disclosed.…more
$2.24-1.54%vs prev closeShareBenzinga - 9.24Pre-market26.09.24 21:02
●●●●●●●● ●●●●● ●●●●●●
Quantum BioPharma's licensee, Unbuzzd Wellness, has appointed Michael Zapolin as its new CEO. The new leadership aims to focus on financing, public listing, and the nationwide rollout of its products in the United States.…more
$2.24-1.54%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report